Any periop, emergency med, or critical care pharmacotherapy topics fair game. Also sometimes implementation science / practice research, lit interpretation, or plants. 🤓💊💉🔬🌱✌

Thank you for your time and consideration, and please share this survey link broadly!  All hospital HCWs who take care of and/or supply medications for critically ill patients are invited, including physicians, prescribers, and hospital pharmacists/pharmacy leadership.

The purpose of this IRB-exempt research study is to characterize current perceptions and practices relating to sugammadex across ED and ICU settings. It is voluntary, anonymous, and should take about 10 minutes to complete. (sorry it is only intended for U.S. practitioners)

Do you have experience and/or opinions regarding sugammadex use in the ICU or Emergency department? We'd be grateful if you took our practice survey here- https://t.co/GHiaYoGzqK #MedTwitter #TwitteRx #FOAMed

#accpam25 Great to catch up with some awesome people at the fellows dinner @AccpPeriopPRN @PharmD_Wong Catch me leading professor walk around rounds for @accpemedprn at the poster session today/ noon Sat 🤓📊

VTE prophylaxis in foot & ankle surgery review- https://t.co/ufhQ7gOUxJ How can we best use limited data and tailor ppx to individual patient risk/benefit in this heterogenous surgical population? 🦶🔪💉💊 What's your approach? #MedTwitter #FOAMed #VTE #FAS

- Now published in these STEMI pharmacotherapy reviews - https://t.co/tnqp9MSFyv… https://t.co/tnqp9MSFyv…

It looks like they just moved the links for some reason, my apologies! https://t.co/osQrpH6CX5 https://t.co/LlAHhCSTY5

@blais_danielle @PharmD_Wong @lichenlady94 #MedTwitter #twitteRx #Cardiology

Thank you to this amazing team of STEMI pharmacist queens 👑💖💊 @blais_danielle @ Marnie Max @ Rachael Eaton @PharmD_Wong @lichenlady94

💔 Surgical med considerations if CABG 💊 Secondary prevention after STEMI 💔 Discharge and transition of care checklists 💊 Patient education 💔 Quality improvement in STEMI care 💊 Pharmacist roles across this continuum and on interventional heart teams

💔 Initial antithrombotics in ED 💊 Supportive therapies in ED 💔 Cath lab- antithrombotics, intraarterial/intracardiac meds 💊 Fibrinolysis- lytic and other med considerations 💔 Early complications- vasoactive and antiarrhythmic therapies 💊 Post-revascularization inpt mgmt

💔Pharmacotherapy of Acute #STEMI 💔 https://t.co/LlAHhCSTY5 https://t.co/osQrpH6CX5 After >3 years (and just in time for new AHA guidelines 😂), our team's 2-part comprehensive review of pharmacotherapy considerations across all phases of STEMI care is now fully published!

Big congrats to @elizabeth_engel for publishing her PGY1 residency project in Hospital Pharmacy! Check it out! @zeeharding @OhioHealth 💉💊 https://t.co/APBqEzgiEC

migrating to

https://t.co/Qt6ZPIG34P

Additional post/description here

How can we best tailor VTE prophylaxis after elective THA/TKA to patient risk, to mitigate both thrombotic and bleeding/wound complications? #orthotwitter Our team at Grant examined our current risk-stratified VTE ppx tool in our recent publication-

Loved this episode about paralytic considerations in #RSI ! Roc vs. Succ? Consider- ⚖️ Comparative efficacy 🧯 Safety/AEs to prepare for 🛟 Reversibility, duration of action 💬 Team's comfort, practice, ideas Thanks for the shoutout @PharmD_intheED 🤜🤛 #MedTwitter #FOAMed

Acute Chest Syndrome Management in Sickle Cell Patients

Let's commend our pharmacy technician colleagues and appreciate the vital importance of a proper med rec at hospital admission! Great work CPhTs Brittany Coon and Valerie Russell on telling these important stories at #OHIOSHP24 👏👏💪